Oric Pharmaceuticals (ORIC) Free Cash Flow (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Free Cash Flow came in at -$32.4 million in Q1 2026, up 1.46% YoY from -$32.0 million in Q1 2025, and down 42.84% on a QoQ basis from -$22.7 million in Q4 2025.
Oric Pharmaceuticals (ORIC) Free Cash Flow (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Free Cash Flow data on file, last reported at -$32.4 million in Q1 2026.
- Quarterly Free Cash Flow rose 1.46% year-over-year to -$32.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$111.2 million (up 4.44% YoY) and the FY2025 annual result came in at -$111.7 million, up 1.9% from the prior year.
- Free Cash Flow eased to -$32.4 million in Q1 2026, from -$22.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$15.6 million in Q4 2022 to a low of -$32.9 million in Q1 2025.
- A 5-year average of -$24.8 million and a median of -$24.3 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow sank 59.36% — and 2025, when it gained 19.68%.
- Tracing ORIC's Free Cash Flow over 5 years: stood at -$15.6 million in 2022, then plunged by 55.78% to -$24.3 million in 2023, then declined by 16.22% to -$28.3 million in 2024, then gained by 19.68% to -$22.7 million in 2025, then tumbled by 42.84% to -$32.4 million in 2026.
- The last three Free Cash Flow figures came in at -$32.4 million (Q1 2026), -$22.7 million (Q4 2025), and -$25.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | -31.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31.96 Mn |
| Jun 30, 2026 | -31.96 Mn |
| Mar 31, 2026 | -32.44 Mn |
| Mar 31, 2026 | -32.44 Mn |
| Dec 31, 2025 | -22.71 Mn |
| Dec 31, 2025 | -22.71 Mn |
| Sep 30, 2025 | -25.15 Mn |
| Sep 30, 2025 | -25.15 Mn |
| Jun 30, 2025 | -30.91 Mn |
| Jun 30, 2025 | -30.91 Mn |
| Mar 31, 2025 | -32.92 Mn |
| Mar 31, 2025 | -32.92 Mn |
| Dec 31, 2024 | -28.27 Mn |
| Dec 31, 2024 | -28.27 Mn |
| Sep 30, 2024 | -29.22 Mn |
| Sep 30, 2024 | -29.22 Mn |
| Jun 30, 2024 | -25.96 Mn |
| Jun 30, 2024 | -25.96 Mn |
| Mar 31, 2024 | -30.40 Mn |
| Mar 31, 2024 | -30.40 Mn |